Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Addex Therapeutics Ltd Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$3.87 | -$3.87 | -$3.87 |
| Q2 2025 | 1 | -$1.29 | -$1.29 | -$1.29 |
| Q3 2025 | 1 | -$1.29 | -$1.29 | -$1.29 |
| Q4 2025 | 1 | -$1.29 | -$1.29 | -$1.29 |
Addex Therapeutics Ltd Earnings Date And Information
Addex Therapeutics Ltd last posted its earnings results on Friday, November 22nd, 2024. The company reported $-2.77 earnings per share for the quarter, missing analysts' consensus estimates of $-0.01 by $2.76. The company had revenue of 53,837 for the quarter and had revenue of 1.61 M for the year. Addex Therapeutics Ltd has generated $0 earnings per share over the last year ($-0.14 diluted earnings per share) and currently has a price-to-earnings ratio of 1.03. Addex Therapeutics Ltd has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based on prior year's report dates.
Addex Therapeutics Ltd Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/22/2024 | Q3 2024 | -$0.01 | -$0.02 | -0.01 | $99,437 | $53,837 |
| 06/29/2024 | Q2 2024 | N/A | $0.13 | N/A | $213,500 | $115,277 |
| 06/06/2024 | Q1 2024 | N/A | -$0.03 | N/A | N/A | $234,910 |
| 11/29/2023 | Q4 2023 | -$4.00 | -$0.03 | 3.97 | N/A | $153,451 |
| 08/10/2023 | Q3 2023 | -$0.83 | -$0.03 | 0.79 | $607,125 | $327,733 |
| 05/11/2023 | Q2 2023 | -$1.03 | -$0.04 | 0.99 | $277,190 | $630,877 |
| 05/11/2023 | Q1 2023 | -$1.03 | -$0.04 | 0.99 | N/A | $500,892 |
| 11/14/2022 | Q4 2022 | N/A | -$0.06 | N/A | N/A | $592,430 |
| 08/18/2022 | Q3 2022 | -$11.20 | -$0.09 | 11.11 | $228,632 | $409,417 |
| 05/05/2022 | Q2 2022 | -$10.40 | -$0.19 | 10.21 | $508,134 | $183,354 |
| 05/05/2022 | Q1 2022 | -$10.40 | -$0.15 | 10.25 | N/A | $237,237 |
| 11/04/2021 | Q4 2021 | -$14.40 | -$0.13 | 14.27 | N/A | $397,488 |
| 08/05/2021 | Q3 2021 | -$13.00 | -$0.11 | 12.89 | $385,446 | $682,002 |
| 05/05/2021 | Q2 2021 | -$13.00 | -$0.14 | 12.86 | $238,081 | $992,595 |
| 05/05/2021 | Q1 2021 | -$13.00 | -$0.08 | 12.92 | N/A | $844,223 |
| 11/03/2020 | Q4 2020 | N/A | -$0.08 | N/A | N/A | $1.82 M |
| 11/03/2020 | Q3 2020 | N/A | -$0.12 | N/A | N/A | $27,264 |
| 06/29/2020 | Q2 2020 | N/A | -$0.12 | N/A | N/A | $860,793 |
| 03/30/2020 | Q1 2020 | N/A | -$0.16 | N/A | N/A | $904,060 |
| 04/24/2020 | Q4 2019 | N/A | -$0.14 | N/A | N/A | $1.04 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Addex Therapeutics Ltd Earnings: FAQ's
Addex Therapeutics Ltd has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 6th, 2025 based offlast year's report dates.
The conference call for Addex Therapeutics Ltd's latest earnings report can be listened to online.
The conference call transcript for Addex Therapeutics Ltd's latest earnings report can be read online.
Addex Therapeutics Ltd (:ADXN) has a recorded annual revenue of $1.61 M.
Addex Therapeutics Ltd (:ADXN) has a recorded net income of $-10,556,227.Addex Therapeutics Ltd has generated $-0.14 earnings per share over the last four quarters.
Addex Therapeutics Ltd (:ADXN) has a price-to-earnings ratio of 1.03 and price/earnings-to-growth ratio is 0.02.